Dafin F Muresanu Selected Research

H290-51

1/2021	Methamphetamine exacerbates pathophysiology of traumatic brain injury at high altitude. Neuroprotective effects of nanodelivery of a potent antioxidant compound H-290/51.
1/2018	Cold Environment Exacerbates Brain Pathology and Oxidative Stress Following Traumatic Brain Injuries: Potential Therapeutic Effects of Nanowired Antioxidant Compound H-290/51.
10/2015	Nanoparticles Exacerbate Both Ubiquitin and Heat Shock Protein Expressions in Spinal Cord Injury: Neuroprotective Effects of the Proteasome Inhibitor Carfilzomib and the Antioxidant Compound H-290/51.
8/2009	Chronic treatment with nanoparticles exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H-290/51.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dafin F Muresanu Research Topics

Disease

17	Edema (Dropsy) 01/2021 - 06/2010
12	Wounds and Injuries (Trauma) 01/2021 - 10/2013
9	Brain Edema (Cerebral Edema) 01/2021 - 01/2012
8	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 01/2015
7	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2012
7	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2012
6	Craniocerebral Trauma (Head Injury) 01/2021 - 01/2019
5	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 10/2015
4	Stroke (Strokes) 01/2021 - 01/2016
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2012
3	Ischemic Stroke 05/2021 - 01/2019
3	Cognitive Dysfunction 05/2021 - 12/2007
3	Brain Injuries (Brain Injury) 01/2020 - 01/2016
2	Heat Stroke (Heatstroke) 01/2021 - 01/2021
2	Sleep Deprivation 01/2020 - 01/2019
2	Brain Diseases (Brain Disorder) 01/2016 - 01/2012
2	Ischemia 01/2016 - 01/2012
2	Nervous System Diseases (Neurological Disorders) 10/2015 - 06/2011
2	Dementia (Dementias) 10/2015 - 08/2009
2	Hypertension (High Blood Pressure) 10/2013 - 12/2007
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 12/2010 - 04/2008
2	Hyperthermia 08/2009 - 12/2007
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Reperfusion Injury 01/2021
1	Coma (Comas) 05/2020
1	Neoplasms (Cancer) 01/2020
1	Gliosis 01/2020
1	Glioma (Gliomas) 01/2020
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020
1	Brain Concussion (Cerebral Concussion) 01/2020

Drug/Important Bio-Agent (IBA)

22	cerebrolysinIBA 01/2021 - 04/2008
12	Neuroprotective AgentsIBA 01/2021 - 12/2007
10	Pharmaceutical PreparationsIBA 01/2021 - 03/2011
8	AntioxidantsIBA 01/2021 - 08/2009
6	Evans Blue (Blue, Evans)FDA Link 01/2021 - 10/2013
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2009
4	Nerve Growth Factors (Neurotrophins)IBA 01/2021 - 06/2011
4	H290-51IBA 01/2021 - 08/2009
4	Histamine (Histamine Dihydrochloride)FDA Link 01/2021 - 01/2017
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 03/2011
3	Growth Hormone (Somatotropin)IBA 10/2015 - 12/2007
2	MetalsIBA 01/2021 - 01/2021
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021 - 10/2015
2	Insulin (Novolin)FDA Link 01/2021 - 10/2015
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2021 - 03/2011
2	Peptides (Polypeptides)IBA 01/2021 - 10/2015
2	Ciliary Neurotrophic Factor (CNTF)IBA 01/2021 - 03/2011
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2021 - 01/2017
2	3-n-butylphthalide (butylphthalide)IBA 01/2020 - 01/2019
2	Therapeutic UsesIBA 01/2020 - 01/2018
2	AntibodiesIBA 01/2019 - 01/2017
2	AlbuminsIBA 01/2018 - 10/2013
2	UbiquitinIBA 01/2016 - 10/2015
2	Blood Proteins (Serum Proteins)IBA 01/2016 - 12/2014
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2015 - 03/2011
1	N-PEP-12IBA 05/2021
1	ginkgolide BIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	beta CateninIBA 01/2021
1	Histamine H4 ReceptorsIBA 01/2021
1	Pregabalin (Lyrica)FDA Link 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	EnzymesIBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2021
1	bilobalideIBA 01/2021
1	oxiracetamIBA 01/2021
1	Malondialdehyde (Propanedial)IBA 01/2021
1	ManganeseIBA 01/2021
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021
1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2021
1	Oxidants (Oxidizing Agents)IBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	Ginkgo biloba extract (Rokan)IBA 01/2021
1	Saline SolutionIBA 05/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	alpha-MSHIBA 01/2020
1	Protein Kinase InhibitorsIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	CytokinesIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2019
1	Neprilysin (Neutral Endopeptidase)IBA 01/2019
1	clobenpropitIBA 01/2018

Therapy/Procedure

7	Therapeutics 01/2021 - 12/2007
6	Drug Therapy (Chemotherapy) 01/2021 - 01/2015
2	Intravenous Administration 01/2019 - 01/2017
1	Continuity of Patient Care 01/2021
1	Diet Therapy (Therapy, Diet) 01/2021
1	Induced Hypothermia 01/2021
1	Nutritional Support (Artificial Feeding) 01/2021
1	Cardiopulmonary Resuscitation (CPR) 01/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021
1	Resuscitation 01/2021
1	Endovascular Procedures 01/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018